Genomic Changes in Head and Neck Cancer
Author Information
Author(s): Ashman J N E, Patmore H S, Condon L T, Cawkwell L, Stafford N D, Greenman J
Primary Institution: University of Hull
Hypothesis
What are the prognostic implications of genomic alterations in head and neck squamous cell carcinoma?
Conclusion
The study found that specific genomic alterations, particularly gains on chromosome 3q and deletions on 22q, are associated with poorer survival outcomes in head and neck squamous cell carcinoma patients.
Supporting Evidence
- Genetic aberrations were detected in all 45 specimens analyzed.
- Mean survival for patients with gain of 3q25–27 was significantly reduced compared to those without.
- Deletion of 22q was associated with a mean survival of 17.0 months compared to 54.9 months for those without.
Takeaway
This study looked at changes in the DNA of patients with head and neck cancer and found that certain changes can help predict how well patients will do.
Methodology
Comparative genomic hybridisation was used to analyze DNA from tumor samples of patients undergoing surgery for head and neck squamous cell carcinoma.
Potential Biases
Potential dilution of CGH signal by normal cell contamination may affect results.
Limitations
The study involved a mixed population of tumor subsites, which may mask subsite-specific genetic markers of prognosis.
Participant Demographics
The cohort included 45 patients, with 35 males and 10 females, undergoing surgery for primary head and neck squamous cell carcinoma.
Statistical Information
P-Value
0.019 for gain of 7p and 0.012 for deletion of 9q
Confidence Interval
95% CI, 28.3–41.7 for mean follow-up duration
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website